Yiming Liu

ORCID: 0000-0001-7200-7197 · 3 papers in corpus
preprint 2024
Immunological Dysregulation in Endometriosis Potentially Linked to Anomalies in NCOA4-Mediated Iron Autophagy Pathway
·doi:10.21203/rs.3.rs-4016800/v1

Abstract Objective This study aims to investigate the expression disparities of Nuclear Receptor Coactivator 4 (NCOA4) in endometriosis (EMS) patients, assessing its diagnostic potential. It also elucidate the correlation between the immu…

rct 2023
Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, a Non-peptide GnRH Antagonist in Premenopausal Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
Clinical pharmacokinetics ·doi:10.1007/s40262-023-01315-6

BACKGROUND: Oral gonadotropin-releasing hormone (GnRH) antagonists are promising agents in the treatment of endometriosis-related pain. Here we assessed the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of SHR7280, an oral non-pe…

case-report 2022
Malignant transformation of rectal endometriosis: Preoperative diagnosis by endorectal ultrasound guided biopsy
Journal of clinical ultrasound : JCU ·doi:10.1002/jcu.23407

The prevalence of malignant transformation of endometriotic lesions is estimated between 0.3% and 1%. Malignant transformations of endometriosis occur in the colorectum is rarer, accounting for 0.25%. Because the malignant transformation of…